檢索結果 - David B. Solit

Refine Results
  1. 1
    Towards a Unified Model of RAF Inhibitor Resistance

    Towards a Unified Model of RAF Inhibitor Resistance 由 David B. Solit, Neal Rosen

    出版 2014
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    KRAS and BRAF: drug targets and predictive biomarkers

    KRAS and BRAF: drug targets and predictive biomarkers 由 Efsevia Vakiani, David B. Solit

    出版 2010
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Targeting the Mitogen-Activated Protein Kinase Pathway: Physiological Feedback and Drug Response

    Targeting the Mitogen-Activated Protein Kinase Pathway: Physiological Feedback and Drug Response 由 Christine A. Pratilas, David B. Solit

    出版 2010
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  4. 4
    Targeting Oncogenic BRAF in Human Cancer

    Targeting Oncogenic BRAF in Human Cancer 由 Christine A. Pratilas, Feng Xing, David B. Solit

    出版 2010
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Combination of RAF and MEK Inhibition for the Treatment of BRAF-Mutated Melanoma: Feedback Is Not Encouraged

    Combination of RAF and MEK Inhibition for the Treatment of BRAF-Mutated Melanoma: Feedback Is Not Encouraged 由 Paul B. Chapman, David B. Solit, Neal Rosen

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    ERK Pathway Inhibitors: How Low Should We Go?

    ERK Pathway Inhibitors: How Low Should We Go? 由 Moriah H. Nissan, Neal Rosen, David B. Solit

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Trametinib in Histiocytic Sarcoma with an Activating <i>MAP2K1</i> (MEK1) Mutation

    Trametinib in Histiocytic Sarcoma with an Activating <i>MAP2K1</i> (MEK1) Mutation 由 Mrinal M. Gounder, David B. Solit, William D. Tap

    出版 2018
    獲取全文
    Carta
    加到收藏夾
    Saved in:
  8. 8
    Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2

    Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2 由 Andrea Basso, David B. Solit, Pamela N. Münster, Neal Rosen

    出版 2002
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Oncogenic Activation of Pak1-Dependent Pathway of Macropinocytosis Determines BCG Entry into Bladder Cancer Cells

    Oncogenic Activation of Pak1-Dependent Pathway of Macropinocytosis Determines BCG Entry into Bladder Cancer Cells 由 Gil Redelman‐Sidi, Gopa Iyer, David B. Solit, Michael S. Glickman

    出版 2013
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    The FDA approval of pembrolizumab for adult and pediatric patients with tumor mutational burden (TMB) ≥10: a decision centered on empowering patients and their physicians

    The FDA approval of pembrolizumab for adult and pediatric patients with tumor mutational burden (TMB) ≥10: a decision centered on empowering patients and their physicians 由 Vivek Subbiah, David B. Solit, Timothy A. Chan, Razelle Kurzrock

    出版 2020
    獲取全文
    Editorial
    加到收藏夾
    Saved in:
  11. 11
    Clinical tumour sequencing for precision oncology: time for a universal strategy

    Clinical tumour sequencing for precision oncology: time for a universal strategy 由 Michael L. Cheng, Michael F. Berger, David M. Hyman, David B. Solit

    出版 2018
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  12. 12
    Akt Forms an Intracellular Complex with Heat Shock Protein 90 (Hsp90) and Cdc37 and Is Destabilized by Inhibitors of Hsp90 Function

    Akt Forms an Intracellular Complex with Heat Shock Protein 90 (Hsp90) and Cdc37 and Is Destabilized by Inhibitors of Hsp90 Function 由 Andrea Basso, David B. Solit, Gabriela Chiosis, Banabihari Giri, Philip N. Tsichlis, Neal Rosen

    出版 2002
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    V600E B-Raf requires the Hsp90 chaperone for stability and is degraded in response to Hsp90 inhibitors

    V600E B-Raf requires the Hsp90 chaperone for stability and is degraded in response to Hsp90 inhibitors 由 Olivera M. Grbovic, Andrea Basso, Ayana Sawai, Q. Ye, Philip Friedlander, David B. Solit, Neal Rosen

    出版 2005
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    <sup>V600E</sup> BRAF is associated with disabled feedback inhibition of RAF–MEK signaling and elevated transcriptional output of the pathway

    <sup>V600E</sup> BRAF is associated with disabled feedback inhibition of RAF–MEK signaling and elevated transcriptional output of the pathway 由 Christine A. Pratilas, Barry S. Taylor, Qing Ye, Agnès Viale, Chris Sander, David B. Solit, Neal Rosen

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells

    The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells 由 Qing‐Bai She, David B. Solit, Qing Ye, Kathryn E. O’Reilly, Jose Lobo, Neal Rosen

    出版 2005
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Association with HSP90 Inhibits Cbl-Mediated Down-regulation of Mutant Epidermal Growth Factor Receptors

    Association with HSP90 Inhibits Cbl-Mediated Down-regulation of Mutant Epidermal Growth Factor Receptors 由 Seungchan Yang, Shimian Qu, Marianela Perez-Tores, Ayana Sawai, Neal Rosen, David B. Solit, Carlos L. Arteaga

    出版 2006
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    PIK3CA Mutation Uncouples Tumor Growth and Cyclin D1 Regulation from MEK/ERK and Mutant KRAS Signaling

    PIK3CA Mutation Uncouples Tumor Growth and Cyclin D1 Regulation from MEK/ERK and Mutant KRAS Signaling 由 Ensar Halilovic, Qing‐Bai She, Qing Ye, Raymond Pagliarini, William R. Sellers, David B. Solit, Neal Rosen

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Pulsatile Administration of the Epidermal Growth Factor Receptor Inhibitor Gefitinib Is Significantly More Effective than Continuous Dosing for Sensitizing Tumors to Paclitaxel

    Pulsatile Administration of the Epidermal Growth Factor Receptor Inhibitor Gefitinib Is Significantly More Effective than Continuous Dosing for Sensitizing Tumors to Paclitaxel 由 David B. Solit, Yuhong She, Jose Lobo, Mark G. Kris, Howard I. Scher, Neal Rosen, Frank Sirotnak

    出版 2005
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    4E-BP1 Is a Key Effector of the Oncogenic Activation of the AKT and ERK Signaling Pathways that Integrates Their Function in Tumors

    4E-BP1 Is a Key Effector of the Oncogenic Activation of the AKT and ERK Signaling Pathways that Integrates Their Function in Tumors 由 Qing‐Bai She, Ensar Halilovic, Qing Ye, Zhen Wei, Senji Shirasawa, Takehiko Sasazuki, David B. Solit, Neal Rosen

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials

    Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials 由 David M. Hyman, David B. Solit, Maria E. Arcila, Donavan T. Cheng, Paul Sabbatini, José Baselga, Michael F. Berger, Marc Ladanyi

    出版 2015
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: